ExOne Co.Find Ratings Reports
EXONE CO's gross profit margin for the third quarter of its fiscal year 2020 has significantly decreased when compared to the same period a year ago. The company grew its sales and net income significantly quarter versus same quarter a year prior, and was able to outpace the average competitor in the subsector when comparing revenue growth, but not when comparing net income growth. EXONE CO has strong liquidity. Currently, the Quick Ratio is 1.78 which shows the ability to cover short-term cash needs. The company's liquidity has increased from the same period last year.
At the same time, stockholders' equity ("net worth") has greatly increased by 36.09% from the same quarter last year. The key liquidity measurements indicate that the company is unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q3 FY20||Q3 FY19|
|Net Sales ($mil)||17.4||10.88|
|Net Income ($mil)||-3.27||-4.84|
|Balance Sheet||Q3 FY20||Q3 FY19|
|Cash & Equiv. ($mil)||39.94||6.12|
|Total Assets ($mil)||97.77||72.22|
|Total Debt ($mil)||7.72||3.66|
|Profitability||Q3 FY20||Q3 FY19|
|Gross Profit Margin||27.11||36.93|
|Return on Assets||-13.2||-15.3|
|Return on Equity||-19.22||-22.39|
|Debt||Q3 FY20||Q3 FY19|
|Share Data||Q3 FY20||Q3 FY19|
|Shares outstanding (mil)||18.99||16.35|
|Div / share||0.0||0.0|
|Book value / share||3.54||3.02|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||1279948.0||423212.0|
HOLD. The current P/E ratio is negative, which has no meaningful value in the assessment of premium or discount valuation, it simply displays that the company has negative earnings. For additional comparison, its price-to-book ratio of 11.24 indicates a significant premium versus the S&P 500 average of 4.14 and a significant premium versus the subsector average of 5.93. The price-to-sales ratio is well above the S&P 500 average, but well below the subsector average. After reviewing these and other key valuation criteria, EXONE CO proves to trade at a premium to investment alternatives.
|XONE NM||Peers 37.71||XONE NM||Peers 17.49|
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.
XONE's P/E is negative making this valuation measure meaningless.
Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
XONE's P/CF is negative making the measure meaningless.
|XONE NM||Peers 28.93||XONE NA||Peers 1.11|
Neutral. The absence of a valid price-to-projected earnings ratio happens when a stock can not be valued on the basis of a negative expected future earnings.
XONE's ratio is negative making this valuation measure meaningless.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
Ratio not available.
|XONE 11.24||Peers 5.93||XONE -13.23||Peers -17.10|
Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
XONE is trading at a significant premium to its peers.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, XONE is expected to significantly trail its peers on the basis of its earnings growth rate.
|XONE 12.71||Peers 1805.47||XONE -2.68||Peers -8.77|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
XONE is trading at a significant discount to its subsector on this measurement.
Higher. A sales growth rate that exceeds the subsector implies that a company is gaining market share.
XONE has a sales growth rate that significantly exceeds its peers.